Leukemia
Move towards pathogenesis-oriented therapy of acute myeloid leukemia warranted
Published in Blood Weekly, February 16th, 2006
According to a study from Germany, "Genetic and molecular techniques have provided increasing insights into the biology of AML. These investigations showed that AML is not a homogeneous disease but a heterogeneous group of biologically different subentities."
"These subentities are currently primarily defined by cytogenetics by which 3 main subgroups can be discriminated: AML with balanced translocations, AML with unbalanced aberrations and AML without cytogenetically detectable aberrations. Within the latter group molecular alterations are identified in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-02-16)
More Articles from Blood Weekly
- Biomedical Engineering
Mild hypothermia preserves bioartificial liver loaded with freshly isolated liver cells - Blood Banking
Germ-free closed system developed for clinical banking of umbilical cord blood - Blood Transfusion
RhD typing for blood transfusion is not needed in southeast Asian populations - Cryopreservation
Trehalose improves cryopreservation of human embryonic stem cells - Tissue Engineering
Chondrocyte-seeded constructs better than unseeded carrier material for knee defect repair - Adult Stem Cells
Powerful technique for multiplying adult stem cells may aid therapies - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
